echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [PDI] Hou Yu: patent information retrieval and analysis to assist the research and development of generic drugs

    [PDI] Hou Yu: patent information retrieval and analysis to assist the research and development of generic drugs

    • Last Update: 2018-05-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Hou Yu, a professor of Hebei University of science and technology, once served as the director of the Institute of science and technology information of Hebei University of science and technology, the master's supervisor of Applied Chemistry in the school of science, and the director of the Institute of chemical pharmacy He has been engaged in research and development in the field of pharmaceutical and chemical industry for more than 20 years, completed more than 20 scientific research projects, provided more than 10 technical services for enterprises, and applied for 6 patents, all of which have been authorized He has published more than 50 papers At the same time of scientific research and teaching of pharmaceutical and chemical engineering, he has a strong interest in information retrieval, information consultation and information resource construction He was also a research and development consultant of many pharmaceutical, chemical and IT enterprises, undertaking professional literature retrieval, translation, special or single variety of technical information research, enterprise technical personnel information skills training, enterprise research and development information support system Unified construction, enterprise product development objectives of the screening and demonstration of information consulting services Hou Yu, Professor of Hebei University of science and technology and President of Kangzhou medical big data development and Application Research Institute, speech title: project selection and analysis of generic drugs From the aspects of risk and return, imitation and innovation, the relationship between chemical drugs and biological drugs, this paper discusses the screening strategy of generic drug project, and introduces two auxiliary tools that can be used in the screening of generic drug project From June 29 to 30, the annual "PDI" conference of the pharmaceutical industry - "the third China Pharmaceutical R & D Innovation Summit and 2018 China's top 100 pharmaceutical R & D strength list" will be held in Chongqing Marriott Hotel This year's theme is "research and development of generic drugs in the new era" Professor Hou Yu will present a wonderful report entitled "screening and analysis of generic drugs" Today, we'd like to share Professor Hou's another wonderful PPT, patent information retrieval and analysis to assist in generic drug research and development I hope it can help you (in addition, if you need the original PPT, you can contact Yao Xiaozhi (wechat: 17318481750) to send it to you separately.).
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.